Wegovy 0.25mg Flextouch Pen

Wegovy 0.25 mg FlexTouch is a prescription medication in a pre-filled injection pen used for chronic weight management. It contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. This product is designed for weekly subcutaneous injection and is typically the starting dose in a gradual dose escalation plan.

Uses:

• Long-term weight management in adults with:
  • Obesity (BMI ≥30)
  • Overweight (BMI ≥27) with at least one weight-related condition (e.g., hypertension, type 2 diabetes, or high cholesterol)
• Used in combination with a reduced-calorie diet and increased physical activity

Benefits:

• Clinically proven to support significant weight loss
• Helps reduce appetite and caloric intake
• Improves metabolic markers such as blood sugar and cholesterol levels
• Convenient once-weekly injection
• Easy-to-use FlexTouch pen for self-administration

Side Effects:

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea or constipation
• Headache
• Fatigue
• Abdominal pain

Serious but rare side effects:

• Pancreatitis
• Gallbladder issues
• Increased heart rate
• Risk of thyroid C-cell tumors (seen in rodents; relevance to humans unknown)

Note: Always consult a healthcare provider before starting Wegovy, especially if you have a history of thyroid cancer or pancreatitis.

Storage:

• Store unopened pens in the refrigerator at 2°C to 8°C (36°F to 46°F)
• Do not freeze
• Keep away from direct heat and sunlight
• Keep out of reach of children